Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.
Pfizer: Three vaccine doses required for sufficient protection from Omicron coronavirus variant
